Adeuyan, O., Gordon, E. R., Lapolla, B. A., Schreidah, C. M., Jobanputra, V., Gru, A. A., & Geskin, L. J. (2024). Superficial Atypical Lipomatous Tumor With Pleomorphic Features: Case Report and Discussion of the Literature. The American Journal of Dermatopathology, 46(8), 509–511. https://doi.org/10.1097/dad.0000000000002745

Gounder, M. M., Bauer, T. M., Schwartz, G. K., Weise, A. M., LoRusso, P., Kumar, P., Tao, B., Hong, Y., Patel, P., Lu, Y., Lesegretain, A., Tirunagaru, V. G., Xu, F., Doebele, R. C., & Hong, D. S. (2023). A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas. Journal of Clinical Oncology, 41(9), 1714–1724. https://doi.org/10.1200/jco.22.01285

Ingham, M., Lee, S., Van Tine, B. A., Choy, E., Oza, J., Doshi, S., Ge, L., Oppelt, P., Cote, G., Corgiat, B., Sender, N., Sta Ana, S., Panchalingam, L., Petricoin, E., & Schwartz, G. K. (2022). A Single-Arm Phase II Trial of Sitravatinib in Advanced Well-Differentiated/Dedifferentiated Liposarcoma. Clinical Cancer Research, 29(6), 1031–1039. https://doi.org/10.1158/1078-0432.ccr-22-3351

Gounder, M. M., Razak, A. A., Somaiah, N., Chawla, S., Martin-Broto, J., Grignani, G., Schuetze, S. M., Vincenzi, B., Wagner, A. J., Chmielowski, B., Jones, R. L., Riedel, R. F., Stacchiotti, S., Loggers, E. T., Ganjoo, K. N., Le Cesne, A., Italiano, A., Garcia del Muro, X., Burgess, M., … Attia, S. (2022). Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Clinical Oncology, 40(22), 2479–2490. https://doi.org/10.1200/jco.21.01829